These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
198 related items for PubMed ID: 11565565
1. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column]. Yeh JH, Chiu HC. J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565 [Abstract] [Full Text] [Related]
2. Optimal volume of processed plasma and total number of selective plasmapheresis sessions in the treatment of patients with severe generalized myasthenia gravis. Yeh JH, Chiu HC. J Clin Apher; 1999 Jun; 14(4):177-80. PubMed ID: 10611627 [Abstract] [Full Text] [Related]
6. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis. Yeh JH, Chiu HC. J Neurol; 2000 Jul; 247(7):510-3. PubMed ID: 10993491 [Abstract] [Full Text] [Related]
7. [Soluble adhesive molecules and cytokines in patients with myasthenia gravis treated with plasmapheresis]. Tesar V, Jelínková E, Jirsa M, Bakosová N, Pit'ha V, Chábová V. Cas Lek Cesk; 1998 Nov 02; 137(21):654-9. PubMed ID: 9929930 [Abstract] [Full Text] [Related]
8. [Diagnostics and treatment of myasthenia gravis in children]. Kroczka S, Steczkowska M, Nowak A, Kaciński M. Przegl Lek; 2008 Nov 02; 65(11):783-8. PubMed ID: 19205361 [Abstract] [Full Text] [Related]
15. Plasmapheresis does not affect polysomnographic parameters in patients with myasthenia gravis: a case series study. Yeh JH, Chen WH, Chiu HC, Lee CT, Hsu CY. Artif Organs; 2010 Jun 02; 34(6):E200-3. PubMed ID: 20456321 [Abstract] [Full Text] [Related]
16. [Seronegative myasthenia gravis]. Bilińska M. Pol Merkur Lekarski; 2002 Jan 02; 12(67):49-53. PubMed ID: 11957803 [Abstract] [Full Text] [Related]
17. [Immunoadsorption therapy for Fisher's syndrome: analysis of the recovery process of external ophthalmoplegia and the removal ability of anti-GQ1b antibodies]. Chida K, Watanabe S, Okita N, Takase S, Tagawa Y, Yuki N. Rinsho Shinkeigaku; 1996 Apr 02; 36(4):551-6. PubMed ID: 8810848 [Abstract] [Full Text] [Related]
18. MuSK antibody clearance during serial sessions of plasmapheresis for myasthenia gravis. Yeh JH, Chen WH, Chiu HC, Bai CH. J Neurol Sci; 2007 Dec 15; 263(1-2):191-3. PubMed ID: 17602704 [Abstract] [Full Text] [Related]
19. Plasmapheresis therapy in myasthenia gravis. Dau PC. Muscle Nerve; 1980 Dec 15; 3(6):468-82. PubMed ID: 7453714 [Abstract] [Full Text] [Related]
20. Long-term treatment of myasthenia gravis with immunoadsorption. Haas M, Mayr N, Zeitlhofer J, Goldammer A, Derfler K. J Clin Apher; 2002 Dec 15; 17(2):84-7. PubMed ID: 12210711 [Abstract] [Full Text] [Related] Page: [Next] [New Search]